BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9331723)

  • 1. Studies on streptococcal NAD-glycohydrolase. Copurification of streptodornase A.
    Gerlach D; Ozegowski JH; Günther E; Vettermann S; Köhler W
    Adv Exp Med Biol; 1997; 418():601-3. PubMed ID: 9331723
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification and some properties of streptococcal NAD-glycohydrolase.
    Gerlach D; Ozegowski JH; Gunther E; Vettermann S; Kohler W
    FEMS Microbiol Lett; 1996 Feb; 136(1):71-8. PubMed ID: 8919458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the NAD-glycohydrolase in streptococcal strains.
    Tatsuno I; Sawai J; Okamoto A; Matsumoto M; Minami M; Isaka M; Ohta M; Hasegawa T
    Microbiology (Reading); 2007 Dec; 153(Pt 12):4253-4260. PubMed ID: 18048938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NAD-glycohydrolase (nga) gene of Streptococcus pyogenes.
    Ajdic D; McShan WM; Savic DJ; Gerlach D; Ferretti JJ
    FEMS Microbiol Lett; 2000 Oct; 191(2):235-41. PubMed ID: 11024269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcal extracellular NAD+ nucleosidase. Characterization of changes occurring during purification.
    Zahradník FJ
    Folia Microbiol (Praha); 1980; 25(1):40-9. PubMed ID: 6243600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and biochemical properties of streptococcal NAD-glycohydrolase inhibitor.
    Kimoto H; Fujii Y; Hirano S; Yokota Y; Taketo A
    J Biol Chem; 2006 Apr; 281(14):9181-9. PubMed ID: 16380378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among Streptococcus pyogenes causing streptococcal toxic shock syndrome.
    Stevens DL; Salmi DB; McIndoo ER; Bryant AE
    J Infect Dis; 2000 Oct; 182(4):1117-28. PubMed ID: 10979908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(+)-glycohydrolase from Streptococcus pyogenes shows cyclic ADP-ribose forming activity.
    Karasawa T; Takasawa S; Yamakawa K; Yonekura H; Okamoto H; Nakamura S
    FEMS Microbiol Lett; 1995 Aug; 130(2-3):201-4. PubMed ID: 7649441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in Streptococcus pyogenes NAD+ glycohydrolase is associated with tissue tropism.
    Riddle DJ; Bessen DE; Caparon MG
    J Bacteriol; 2010 Jul; 192(14):3735-46. PubMed ID: 20494994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of polymorphic residues reveals distinct enzymatic and cytotoxic activities of the Streptococcus pyogenes NAD+ glycohydrolase.
    Chandrasekaran S; Ghosh J; Port GC; Koh EI; Caparon MG
    J Biol Chem; 2013 Jul; 288(27):20064-75. PubMed ID: 23689507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel endogenous inhibitor of the secreted streptococcal NAD-glycohydrolase.
    Meehl MA; Pinkner JS; Anderson PJ; Hultgren SJ; Caparon MG
    PLoS Pathog; 2005 Dec; 1(4):e35. PubMed ID: 16333395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and properties of streptococcal nicotinamide adenine dinucleotide glycohydrolase.
    Grushoff PS; Shany S; Bernheimer AW
    J Bacteriol; 1975 May; 122(2):599-605. PubMed ID: 236282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcal extracellular NAD-glycohydrolase. Optimal temperature and activation by cysteine.
    Zahradník FJ
    Folia Microbiol (Praha); 1977; 22(2):92-7. PubMed ID: 191337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of Streptococcus pyogenes NAD(+) glycohydrolase in cytolysin-mediated translocation.
    Ghosh J; Caparon MG
    Mol Microbiol; 2006 Nov; 62(4):1203-14. PubMed ID: 17042787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci.
    Bricker AL; Cywes C; Ashbaugh CD; Wessels MR
    Mol Microbiol; 2002 Apr; 44(1):257-69. PubMed ID: 11967084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of the Pathogenic Features of Streptococcus pyogenes Isolates from Invasive and Non-Invasive Diseases in Aichi, Japan.
    Matsumoto M; Yamada K; Suzuki M; Adachi H; Kobayashi S; Yamashita T; Minagawa H; Tatsuno I; Hasegawa T
    Jpn J Infect Dis; 2016 Jul; 69(4):338-41. PubMed ID: 26567838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD(+)-glycohydrolase productivity of haemolytic streptococci assayed by a simple fluorescent method and its relation to T serotype.
    Karasawa T; Yamakawa K; Tanaka D; Gyobu Y; Nakamura S
    FEMS Microbiol Lett; 1995 May; 128(3):289-92. PubMed ID: 7781977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of Streptococcus pyogenes immunity to its NAD+ glycohydrolase toxin.
    Smith CL; Ghosh J; Elam JS; Pinkner JS; Hultgren SJ; Caparon MG; Ellenberger T
    Structure; 2011 Feb; 19(2):192-202. PubMed ID: 21300288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of streptodornase from Streptococcus equisimilis and its DNA-induced conformational change.
    Lee M; Song KB
    Biochem Biophys Res Commun; 1997 Jan; 230(1):13-5. PubMed ID: 9020028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution crystal structure of Streptococcus pyogenes β-NAD⁺ glycohydrolase in complex with its endogenous inhibitor IFS reveals a highly water-rich interface.
    Yoon JY; An DR; Yoon HJ; Kim HS; Lee SJ; Im HN; Jang JY; Suh SW
    J Synchrotron Radiat; 2013 Nov; 20(Pt 6):962-7. PubMed ID: 24121349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.